KRRO

Korro Bio Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth↓ 3/10
  • Value↓ 0/10
Korro Bio sales and earnings growth
KRRO Growth
Neutral
  • Revenue Y/Y↑ 181.46%
  • EPS Y/Y↓ -33.19%
  • FCF Y/Y↓ -1.41%
Korro Bio gross and profit margin trends
KRRO Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -1834.50%
  • ROIC 5Y↓ -85.48%
Korro Bio net debt vs free cash flow
KRRO Risk
Great
  • Debt / Equity↓ 0.8
  • Debt / FCF↓ 0.3
  • Interest coverage↑ 999.0

Korro Bio stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗